Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accrual, AVANOVA, bevacizumab, BRAVO, choose, companion, Comparison, death, demonstrated, diagnostic, efficacy, effort, expended, Fee, force, fourth, gBRCAmut, Gynaecological, Gynecologic, half, heading, HRD, infrastructure, inherent, intent, KEYTRUDA, label, ligand, linked, molecule, Network, Nordic, NOVA, objective, OPDIVO, open, pharmacology, poor, predefined, Prescription, presence, PRIMA, promising, promotional, proposed, protein, QUADRA, release, resistant, responded, RSU, shown, sponsor, sponsored, standard, type, usage, User, vivo
Removed:
add, addressed, amendment, annualized, ascribed, called, certificate, clinic, collaborative, consultant, developed, discontinued, disposal, enable, enrolled, facility, feasibility, Finally, globally, highly, incorporating, individually, insignificant, landlord, magnitude, mg, milligram, mutual, notice, occurring, proportionate, prospectively, qualify, reached, reduction, reimbursing, retrospective, security, shift, stage, sublicenseable, variable, written
Filing tables
Filing exhibits
Related press release
TSRO similar filings
Filing view
External links